| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 131,044 | 149,307 | 140,652 | 165,504 | | Cost of Revenue | 54,938 | 58,366 | 53,008 | 55,397 | | | Gross Profit | 76,106 | 90,941 | 87,644 | 110,107 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 6,856 | 6,894 | 7,645 | 10,244 | | Non Recurring | 52 | 129 | (229) | 48 | | Others | 9,538 | 9,529 | 8,143 | 7,909 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 60,062 | 74,389 | 72,085 | 91,906 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 427 | 90 | 52 | 115 | | Earnings Before Interest And Taxes | 60,087 | 74,479 | 72,137 | 92,021 | | Interest Expense | 649 | 735 | 604 | 305 | | Income Before Tax | 59,438 | 73,744 | 71,533 | 91,716 | | Income Tax Expense | 11,154 | 6,073 | 15,106 | 13,353 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 48,284 | 67,671 | 56,427 | 78,363 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 48,284 | 67,671 | 56,427 | 78,363 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $48,284 | $67,671 | $56,427 | $78,363 |
|
0.24% Nasdaq 
0.01%
Income Statement
